ACI - Weight-loss drugs cut grocery bills by up to 9% - Morgan Stanley
2024-02-18 18:29:58 ET
More on Eli Lilly, Novo Nordisk
- Novo Nordisk: Irrational Exuberance Isn't Worth The Risk
- Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric
- Novo Nordisk: These Bold Moves Point Toward Upside
- Could Eli Lilly be the first $1T biopharma stock? Morgan Stanley asks
- Eli Lilly obesity therapy tirzepatide being rolled out in the U.K.